LIGAND PHARMACEUTICALS INCORPORATED Operating Loss Carryforwards, Valuation Allowance
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Operating Loss Carryforwards, Valuation Allowance of $8.90 million as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwardsValuationAllowance · last filed 2016-11-14
- 2016-09-30: Operating Loss Carryforwards, Valuation Allowance $8.90M.
- 2016-06-30: Operating Loss Carryforwards, Valuation Allowance $8.90M.
- 2016-03-31: Operating Loss Carryforwards, Valuation Allowance $8.90M.
- 2015-09-30: Operating Loss Carryforwards, Valuation Allowance $9.10M.
| Period end | Operating Loss Carryforwards, Valuation Allowance |
|---|---|
| 2016-09-30 | $8.90M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $8.90M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $8.90M 10-Q · filed 2016-11-14 |
| 2015-09-30 | $9.10M 10-Q · filed 2015-11-09 |